Computer System Validation (CSV), Software & Data Integrity

Aligning Global Sites on 21 CFR Part 11 and Annex 11 Interpretation Aligning Global Sites on 21 CFR Part 11 and Annex 11 Interpretation In the pharmaceutical and life sciences industries, compliance with regulatory frameworks is paramount. Two significant regulations that focus on the management of electronic records and signatures are 21 CFR Part 11, enforced by the US FDA,…

Case Studies of FDA 483 and Warning Letters Related to Part 11 Failures Case Studies of FDA 483 and Warning Letters Related to Part 11 Failures The validation of computerized systems in the pharmaceutical industry is critical in ensuring compliance with regulatory requirements such as 21 CFR Part 11 and EU Annex 11. These regulations govern electronic records, electronic signatures,…

Developing Part 11 and Annex 11 Policies, SOPs and Governance Frameworks Developing Part 11 and Annex 11 Policies, SOPs and Governance Frameworks In today’s fast-paced pharmaceutical environment, the integrity of electronic records and e-signatures is paramount. The importance of adhering to regulatory guidelines such as 21 CFR Part 11 and EU Annex 11 cannot be overstated. These regulations establish the…

Handling Hybrid Records and Scanned Documents in a Part 11 Environment Handling Hybrid Records and Scanned Documents in a Part 11 Environment In the evolving landscape of pharmaceutical operations, the approach to managing records has become increasingly complex, particularly with the advent of hybrid records environments. The interface of paper and electronic documents presents unique challenges, especially under the regulatory…

Cybersecurity and Data Integrity Considerations in Part 11 Controlled Systems The integration of cybersecurity into pharmaceutical systems regulated by 21 CFR Part 11 and EU Annex 11 reflects a growing recognition of data integrity as fundamental to compliance in Good Automated Manufacturing Practice (GxP) environments. This regulatory explainer manual addresses the expectations highlighted in various guidance documents from authorities such…

Inspection Ready Part 11 and Annex 11 Evidence Packs for Regulators As the pharmaceutical industry navigates the complexities of regulatory compliance, understanding the requirements for 21 CFR Part 11 in the United States and EU Annex 11 is essential. These regulations govern electronic records and electronic signatures, requiring companies to ensure that their practices align with Good Manufacturing Practices (cGMP)….

Audit Trail Review Training for QA and System Owners Practical Workshops Audit Trail Review Training for QA and System Owners Practical Workshops In the landscape of pharmaceutical compliance, maintaining the integrity of electronic records through effective audit trail review training is paramount. This detailed guide outlines the steps to develop a workshop tailored for Quality Assurance (QA) professionals and system…

Developing Risk Based Controls for E-Records Under Part 11 and Annex 11 The increasing reliance on electronic records in the pharmaceutical industry necessitates a robust understanding of the regulatory frameworks governing these practices. The US FDA’s 21 CFR Part 11 and the EU’s Annex 11 outline stringent requirements that ensure the integrity and security of electronic records and e-signatures. As…

Configuring Time Synchronisation and Audit Trail Time Stamps in GxP Systems Configuring Time Synchronisation and Time Stamp Controls in GxP Systems Introduction to Time Synchronisation in Regulatory Context In the pharmaceutical and biotechnology industries, compliance with Good Automated Manufacturing Practice (GxP) standards is imperative for ensuring the integrity and reliability of electronic records. A critical component of these records is…

ERP Validation in GxP Environments Managing Inventory, Finance and Quality ERP Validation in GxP Environments Managing Inventory, Finance and Quality Enterprise Resource Planning (ERP) systems play a critical role in managing inventory, finance, and quality within GxP (Good Practice) environments. The validation of these systems ensures compliance with regulatory requirements set forth by authorities like the US FDA, EMA, MHRA,…